Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
X4 Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
XFOR
Nasdaq
2834
www.x4pharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals (XFOR) Loses 20.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- Sep 11th, 2026 7:35 am
X4 Pharmaceuticals to Participate in a Fireside Chat at the 2026 Wells Fargo Healthcare Conference
- Sep 9th, 2026 5:00 am
X4 Pharmaceuticals Announces Positive Outcome from FDA Type C Meeting
- Sep 8th, 2026 5:00 am
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Sep 1st, 2026 2:30 pm
X4 Pharmaceuticals (XFOR) Upgraded to Buy: Here's Why
- Aug 11th, 2026 10:00 am
X4 Pharmaceuticals (XFOR) Reports Q2 Loss, Beats Revenue Estimates
- Aug 6th, 2026 5:10 pm
X4 Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update
- Aug 6th, 2026 2:15 pm
Sarepta Therapeutics (SRPT) Q2 Earnings and Revenues Surpass Estimates
- Aug 5th, 2026 6:35 pm
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Jul 7th, 2026 2:30 pm
X4 Pharmaceuticals Appoints Kelly Gold, Experienced Chief Financial Officer, to its Board of Directors
- Jul 1st, 2026 5:00 am
X4 Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
- May 27th, 2026 5:00 am
How The X4 Pharmaceuticals (XFOR) Story Is Shifting With Mavorixafor And New EU Progress
- May 20th, 2026 10:33 pm
Here is Why X4 Pharmaceuticals (XFOR) is Among the Unrivaled Penny Stocks to Buy Now
- May 14th, 2026 11:39 am
X4 Pharmaceuticals (XFOR) Reports Q1 Loss, Lags Revenue Estimates
- May 6th, 2026 6:25 am
X4 Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
- May 6th, 2026 5:15 am
Scroll